Medsolve Dynamics

About Medsolve Dynamics

Executive Strategy Meets Clinical Reality. Innovation is expensive. Solvency is mandatory. Margins die in the gap between strategy and execution. Medsolve Dynamics is an oncology consulting firm working with cancer centers, hospital radiation oncology programs and MedTech organizations making capital decisions they cannot reverse, managing reimbursement pressure they did not budget for, and evaluating AI tools that do not map to their actual workflow. THE REALITY Oncology delivery operates with minimal margin for error. In radiation oncology alone, expense ratios routinely approach 75 percent. Too often the ROI promised in a capital or technology decision evaporates when it reaches the P&L. Medsolve validates whether a program can staff it, schedule it and pay for it before it signs. THE FIRM Led by Yoel Bakas, who spent 20 years on the vendor side of every major deal in radiation oncology. GE HealthCare, ViewRay, Varian, Mevion. That experience now sits on the buyer's side of the table, paired with ground-level validation from active clinical physicists and hospital administrators. Recommendations survive operational, regulatory and accreditation reality. WHERE MEDSOLVE IS TRUSTED Capital Strategy: radiation oncology capital planning, LINAC replacement timing, vendor-neutral deal structure, service contract intelligence and negotiation leverage. Financial Strategy: cancer center proformas, revenue protection, reimbursement exposure, APEx and ACR complexity. AI Reality Check: validating AI in radiation oncology against workflow, staffing and economics. Revenue & Margin Growth: theranostics, benign disease, adaptive therapy and high-margin service line frameworks. The principle is simple. You cannot buy the future of cancer care if you cannot pay for the present. Main site: medsolvedynamics.com 2026 Executive Diagnostic: medsolve.ai Contact: team@medsolvedynamics.com